FeesSafety
Pluang+

Hamilton Lane raises quarterly dividend 11% to $0.60 per share for Q2 fiscal 2027.

Company Fundamentals
03 Nov 2026, 14:00 WIB
PRNewsWire
View Source
Bullish
Hamilton Lane raises quarterly dividend 11% to $0.60 per share for Q2 fiscal 2027.

Hamilton Lane announced an 11% increase in its quarterly dividend to $0.60 per share for the second fiscal quarter ended September 30, 2026, with the full-year target dividend at $2.40. The dividend will be paid on January 7, 2027, to shareholders of record as of December 21, 2026. The company also reported its Q2 fiscal 2027 results and will hold a webcast to discuss the performance. Hamilton Lane manages approximately $1.1 trillion in assets and specializes in private markets investment solutions globally.

Hamilton Lane Incorporated's recent fiscal report provides context for readers interested in financial sector trends. For readers following the Financials sector, here is Pluang's market snapshot as of Nov 03, 2026 18:42 WIB: out of 142 priced US Financials stocks tradable on Pluang, 56 rose and 77 fell today. Notable movers include VLY at USD 14.28 with a 1-day change of -1.18%, MFC at USD 45.28 with a 1-day change of +1.17% and 100% sell order activity, and CRBG at USD 34.64 with a 1-day change of -1.14%.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App